-
-
Controlled substance diversion is one of those things that every administrator thinks "could never happen to me. I don't have any thieves or drug abusers working here." In my 20 years of being a pharmacist consultant for surgery centers, I've heard that more times than I can count.
-
About one-quarter of healthcare respondents reported that their organization has experienced a security breach in the past year, according to survey results from the Healthcare Information Management and Systems Society (HIMSS) in Chicago.
-
More often, outpatient surgery staff members find themselves in the unenviable position of telling patients about out-of-pocket responsibilities running into the thousands of dollars.
-
[Editor's note: In this issue of Same-Day Surgery, we put a special focus on compliance with regulated drugs. We've talked with some of the top pharmacy consultants in the country to find out foolproof systems for avoiding diversion and theft. These stories will help you decide where to focus your time and energy, while avoiding liability.]
-
-
-
Updates to the darunavir (Prezista®) package insert, specifically sections: 6 Adverse Reactions, 12.4 Microbiology, 14 Clinical Studies and were approved on Oct. 19, 2011, to include results from the 192-week safety, resistance and efficacy data from study TMC114-C211, "A randomized, controlled, open-label Phase 3 trial comparing darunavir/ritonavir 800/100 mg once daily versus lopinavir/ritonavir 800/200 mg per day (given as a twice daily or as a once daily regimen) in antiretroviral treatment-naïve HIV-1-infected adult subjects."
-
Thirty years after the world first became aware of a strange syndrome that caused young men to acquire rare diseases like Pneumocystis carinii pneumonia (PCP) and Kaposi's Sarcoma, nations across the globe continue to battle against the HIV/AIDS epidemic.
-
One obstacle to the success of the U.S. national HIV/AIDS strategy involves the accuracy of metrics used for monitoring HIV care, including late diagnoses and linkage to sustained care, a new study notes.
